Loading...
VIT logo

Vitura Health LimitedASX:VIT Stock Report

Market Cap AU$14.6m
Share Price
n/a
1Y-64.5%
7D-24.1%
1D4.8%
Portfolio Value
​
View

Vitura Health Limited

ASX:VIT Stock Report

Market Cap: AU$14.6m

Vitura Health (VIT) Stock Overview

Engages in the sale and distribution of medicinal cannabis products in Australia. More details

VIT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends2/6

Rewards

Trading at 62.8% below our estimate of its fair value

Risk Analysis

Dividend of 9.09% is not well covered by earnings or free cash flows

Does not have a meaningful market cap (A$15M)

Profit margins (0.6%) are lower than last year (1.5%)

Significant insider selling over the past 3 months


VIT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Vitura Health Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vitura Health
Historical stock prices
Current Share PriceAU$0.022
52 Week HighAU$0.075
52 Week LowAU$0.021
Beta-1.4
1 Month Change-35.29%
3 Month Change-45.00%
1 Year Change-64.52%
3 Year Change-95.73%
5 Year Change-80.00%
Change since IPO-93.53%

Recent News & Updates

Recent updates

Analysis Article • Jun 20

Vitura Health Limited's (ASX:VIT) Low P/S No Reason For Excitement

With a price-to-sales (or "P/S") ratio of 0.3x Vitura Health Limited ( ASX:VIT ) may be sending very bullish signals at...
Analysis Article • Feb 19

Vitura Health Limited (ASX:VIT) Stock Catapults 54% Though Its Price And Business Still Lag The Industry

Vitura Health Limited ( ASX:VIT ) shares have had a really impressive month, gaining 54% after a shaky period...
Analysis Article • Oct 17

There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise

Vitura Health Limited ( ASX:VIT ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Oct 13

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • Sep 07

Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Vitura Health Limited's ( ASX:VIT ) stock was strong despite it releasing a soft earnings report last week. We think...
Analysis Article • Aug 12

Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Vitura Health Limited ( ASX:VIT ) shareholders that were waiting for something to happen have been dealt a blow with a...
Analysis Article • Aug 12

Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

The Vitura Health Limited ( ASX:VIT ) share price has fared very poorly over the last month, falling by a substantial...
Analysis Article • Apr 25

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

To the annoyance of some shareholders, Vitura Health Limited ( ASX:VIT ) shares are down a considerable 43% in the last...
Analysis Article • Apr 11

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Feb 27

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Unfortunately for some shareholders, the Vitura Health Limited ( ASX:VIT ) share price has dived 37% in the last thirty...
Analysis Article • Feb 25

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article • Dec 13

Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Key Insights Vitura Health's estimated fair value is AU$0.25 based on Dividend Discount Model Current share price of...
Analysis Article • Nov 21

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Key Insights Vitura Health to hold its Annual General Meeting on 27th of November CEO Rodney Cocks' total compensation...
Analysis Article • Nov 01

Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Jul 18

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analysis Article • Sep 12

Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

Despite an already strong run, Cronos Australia Limited ( ASX:CAU ) shares have been powering on, with a gain of 111...
Analysis Article • Sep 05

If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Shareholder Returns

VITAU PharmaceuticalsAU Market
7D-24.1%-4.0%-1.8%
1Y-64.5%-21.6%1.8%

Return vs Industry: VIT underperformed the Australian Pharmaceuticals industry which returned -21.6% over the past year.

Return vs Market: VIT underperformed the Australian Market which returned 1.8% over the past year.

Price Volatility

Is VIT's price volatile compared to industry and market?
VIT volatility
VIT Average Weekly Movement9.5%
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement9.9%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market4.0%

Stable Share Price: VIT has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: VIT's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2018n/aJustin Jamesvitura.com.au

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations.

Vitura Health Limited Fundamentals Summary

How do Vitura Health's earnings and revenue compare to its market cap?
VIT fundamental statistics
Market capAU$14.58m
Earnings (TTM)AU$784.13k
Revenue (TTM)AU$129.24m
18.6x
P/E Ratio
0.1x
P/S Ratio

Is VIT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIT income statement (TTM)
RevenueAU$129.24m
Cost of RevenueAU$96.91m
Gross ProfitAU$32.32m
Other ExpensesAU$31.54m
EarningsAU$784.13k

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.0012
Gross Margin25.01%
Net Profit Margin0.61%
Debt/Equity Ratio28.8%

How did VIT perform over the long term?

See historical performance and comparison

Dividends

9.1%
Current Dividend Yield
167%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/26 17:11
End of Day Share Price 2026/06/26 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vitura Health Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anubhav SaxenaBell Potter